Elizabeth K. Harmon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elizabeth K. Harmon has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Kevin P. Battaile
New York Structural Biology Center
6 shared publications - Scott Lovell
Protein Structure and X-ray Crystallography Laboratory, University of Kansas, Lawrence, KS 66047, USA
6 shared publications - Oluwatoyin Ajibola Asojo
Dartmouth Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
4 shared publications - Peter J. Myler
Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA 98109, USA
4 shared publications - Lijun Liu
Protein Structure and X-ray Crystallography Laboratory, Del Shankel Structural Biology Center, University of Kansas , Lawrence, Kansas
3 shared publications - Lijun Liu
Protein Structure and X-ray Crystallography Laboratory, University of Kansas, 2034 Becker Drive, Lawrence, KS 66047, USA
3 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Springer Nature in Scientific Reports
Characterization of plasmodium SEY1, an essential dynamin-like GTPase and potential anti-malarial druggable target
In some species, SEY1 is a predicted essential dynamin-like GTPase that is implicated in homotypic fusion of endoplasmic reticulum membranes. SEY1 family members are conserved among eukaryotic pathogens, but they show minimal similarity to human atlastins. Here, we characterize Plasmodium SEY1 proteins. Through conditional knockdown and epitope tagging studies in P. falciparum, we demonstrate that SEY1 is essential, localizes within the endoplasmic reticulum, and its disruption leads to defects in endoplasmic reticulum morphology. We show that P. vivax SEY1 can be recombinantly expressed as a soluble truncated isoform. This protein maintains its catalytic activity and ability to dimerize. It also possesses a moderate K d for GTP and is amenable to high throughput inhibition studies. Our data show that SEY1 is a new and attractive druggable and assayable target that is conserved across Plasmodium species.
- 2 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessCharacterization of plasmodium SEY1, an essential dynamin-like GTPase and potential anti-malarial druggable target
In some species, SEY1 is a predicted essential dynamin-like GTPase that is implicated in homotypic fusion of endoplasmic reticulum membranes. SEY1 family members are conserved among eukaryotic pathogens, but they show minimal similarity to human atlastins. Here, we characterize Plasmodium SEY1 proteins. Through conditional knockdown and epitope tagging studies in P. falciparum, we demonstrate that SEY1 is essential, localizes within the endoplasmic reticulum, and its disruption leads to defects in endoplasmic reticulum morphology. We show that P. vivax SEY1 can be recombinantly expressed as a soluble truncated isoform. This protein maintains its catalytic activity and ability to dimerize. It also possesses a moderate K d for GTP and is amenable to high throughput inhibition studies. Our data show that SEY1 is a new and attractive druggable and assayable target that is conserved across Plasmodium species.
- Open Access
- 5 May 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 82 (6) , 194-200
Crystal structure of Plasmodium vivax macrophage migration inhibitory factor
Plasmodium vivax is a major cause of malaria globally and has recently been transmitted locally in the USA. P. vivax produces homologs of host proteins, including cytokines such as macrophage migration inhibitory factor (MIF). MIF regulates both adaptive and innate immune responses and contributes to the pathogenesis of parasitic infections, including malaria. Plasma concentrations of P. vivax MIF ( Pv MIF) correlate with the severity of P. vivax malaria. Plasmodium spp. MIFs have been recognized as candidate malaria vaccines. Pv MIF, like other protozoan MIFs, binds to host CD74 and can suppress host MIF–CD74 signaling. The production, crystallization and 1.8 Å resolution structure of Pv MIF (PDB entry 9b0m, pdb_00009b0m) are reported. Pv MIF crystallized in space group P 6 3 with a single molecule in the asymmetric unit. The biological unit of Pv MIF is the prototypical MIF trimer.
- 5 May 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 82 (6) , 194-200
Open AccessCrystal structure of Plasmodium vivax macrophage migration inhibitory factor
Plasmodium vivax is a major cause of malaria globally and has recently been transmitted locally in the USA. P. vivax produces homologs of host proteins, including cytokines such as macrophage migration inhibitory factor (MIF). MIF regulates both adaptive and innate immune responses and contributes to the pathogenesis of parasitic infections, including malaria. Plasma concentrations of P. vivax MIF ( Pv MIF) correlate with the severity of P. vivax malaria. Plasmodium spp. MIFs have been recognized as candidate malaria vaccines. Pv MIF, like other protozoan MIFs, binds to host CD74 and can suppress host MIF–CD74 signaling. The production, crystallization and 1.8 Å resolution structure of Pv MIF (PDB entry 9b0m, pdb_00009b0m) are reported. Pv MIF crystallized in space group P 6 3 with a single molecule in the asymmetric unit. The biological unit of Pv MIF is the prototypical MIF trimer.
- Open Access
- 4 May 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (5) , e1072-e1082
Structure-Guided Design of Calcium-Dependent Protein Kinase 1 Inhibitors for Cryptosporidiosis
Background: Calcium-dependent protein kinase 1 (CDPK1) has emerged as a protozoan-specific target for the treatment of cryptosporidiosis. A previous study identified pyridopyrimidinones as new Cryptosporidium parvum CDPK1 (CpCDPK1) inhibitors with potent growth inhibition against C. parvum and Cryptosporidium hominis. Docking analyses suggested the unique positioning of the kinase's αC-helix could present refinement opportunities. Methods: Compounds designed to optimize the pyridopyrimidinones focused on the back-pocket region predicted to be proximal to the αC-helix, the solvent-exposed region, and the ATP ribose-binding site. Designed derivatives were synthesized and assessed for CpCDPK1 and Src kinase inhibition and for Cryptosporidium spp growth inhibition in mammalian cells. AMP/Mg+2 and 3 inhibitors were cocrystalized with CpCDPK1, and 2 inhibitors were profiled for kinase selectivity. Results: WIN 4-88 was identified with CpCDPK1 (half maximum inhibitory concentration [IC50] = 0.056 μM), and growth inhibition of zoonotic C. parvum NLuc (half maximum effective concentration [EC50] = 0.042 μM), anthroponotic C. parvum Tu114 (EC50 = 0.030 μM), and C. hominis Tu502 (EC50 = 0.062 μM), as well as enhanced kinome selectivity. The crystal structures confirmed the predicted binding mode, indicating key interactions with hinge residue Y155, similar orientations of the solvent-expose moieties, occupancy of the back pocket near the αC-helix, and for 1 inhibitor containing a solubilizing hydroxyethyl attached to the central heterocycle extension into the ATP ribose-binding site. Conclusions: The expanded structure-activity relationship and structural insights will potentially be applicable to other chemotypes with similar binding modes and will enhance development of CpCDPK1 inhibitors for the treatment of cryptosporidiosis.
- 4 May 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (5) , e1072-e1082
Open AccessStructure-Guided Design of Calcium-Dependent Protein Kinase 1 Inhibitors for Cryptosporidiosis
Background: Calcium-dependent protein kinase 1 (CDPK1) has emerged as a protozoan-specific target for the treatment of cryptosporidiosis. A previous study identified pyridopyrimidinones as new Cryptosporidium parvum CDPK1 (CpCDPK1) inhibitors with potent growth inhibition against C. parvum and Cryptosporidium hominis. Docking analyses suggested the unique positioning of the kinase's αC-helix could present refinement opportunities. Methods: Compounds designed to optimize the pyridopyrimidinones focused on the back-pocket region predicted to be proximal to the αC-helix, the solvent-exposed region, and the ATP ribose-binding site. Designed derivatives were synthesized and assessed for CpCDPK1 and Src kinase inhibition and for Cryptosporidium spp growth inhibition in mammalian cells. AMP/Mg+2 and 3 inhibitors were cocrystalized with CpCDPK1, and 2 inhibitors were profiled for kinase selectivity. Results: WIN 4-88 was identified with CpCDPK1 (half maximum inhibitory concentration [IC50] = 0.056 μM), and growth inhibition of zoonotic C. parvum NLuc (half maximum effective concentration [EC50] = 0.042 μM), anthroponotic C. parvum Tu114 (EC50 = 0.030 μM), and C. hominis Tu502 (EC50 = 0.062 μM), as well as enhanced kinome selectivity. The crystal structures confirmed the predicted binding mode, indicating key interactions with hinge residue Y155, similar orientations of the solvent-expose moieties, occupancy of the back pocket near the αC-helix, and for 1 inhibitor containing a solubilizing hydroxyethyl attached to the central heterocycle extension into the ATP ribose-binding site. Conclusions: The expanded structure-activity relationship and structural insights will potentially be applicable to other chemotypes with similar binding modes and will enhance development of CpCDPK1 inhibitors for the treatment of cryptosporidiosis.
- Open Access
Trichomonas vaginalis PPi-dependent phosphofructokinase structures reveal a non-canonical nucleotide binding site
Pyrophosphate-dependent phosphofructokinases provide an alternative route through central carbon metabolism by using inorganic pyrophosphate rather than ATP to phosphorylate fructose-6-phosphate. These enzymes are absent from mammals but occur in several anaerobic and parasitic organisms, where they may support metabolic flexibility and represent potential therapeutic vulnerabilities. Here, we report three crystal structures of Trichomonas vaginalis PPi-dependent phosphofructokinase 1 (TvPPi-PFK), a cytosolic enzyme that contributes substantially to parasite glycolytic flux. The structures show that TvPPi-PFK adopts the conserved two-domain PFK fold, assembles as a tetramer, and preserves the canonical PPi/MgPPi²⁻-binding motifs required for pyrophosphate-dependent catalysis. Mass photometry confirms that TvPPi-PFK is predominantly tetrameric in solution and shows that nucleotide- and Mg²⁺/PPi-containing conditions further stabilize the tetrameric assembly. Unexpectedly, the ligand-bound structures reveal ATP, AMP, and sugar-phosphate ligands at a recurring dimer-interface site that is spatially distinct from the canonical PPi/MgPPi²⁻ catalytic donor-binding pocket. This non-canonical interface is more accessible in TvPPi-PFK than in available PPi-PFK structures, suggesting a previously unrecognized ligand-recognition feature. These findings expand the structural landscape of the PFK superfamily and provide a framework for testing how nucleotide and sugar-phosphate binding may influence TvPPi-PFK function, regulation, and future antitrichomonal drug-discovery efforts.
Open AccessTrichomonas vaginalis PPi-dependent phosphofructokinase structures reveal a non-canonical nucleotide binding site
Pyrophosphate-dependent phosphofructokinases provide an alternative route through central carbon metabolism by using inorganic pyrophosphate rather than ATP to phosphorylate fructose-6-phosphate. These enzymes are absent from mammals but occur in several anaerobic and parasitic organisms, where they may support metabolic flexibility and represent potential therapeutic vulnerabilities. Here, we report three crystal structures of Trichomonas vaginalis PPi-dependent phosphofructokinase 1 (TvPPi-PFK), a cytosolic enzyme that contributes substantially to parasite glycolytic flux. The structures show that TvPPi-PFK adopts the conserved two-domain PFK fold, assembles as a tetramer, and preserves the canonical PPi/MgPPi²⁻-binding motifs required for pyrophosphate-dependent catalysis. Mass photometry confirms that TvPPi-PFK is predominantly tetrameric in solution and shows that nucleotide- and Mg²⁺/PPi-containing conditions further stabilize the tetrameric assembly. Unexpectedly, the ligand-bound structures reveal ATP, AMP, and sugar-phosphate ligands at a recurring dimer-interface site that is spatially distinct from the canonical PPi/MgPPi²⁻ catalytic donor-binding pocket. This non-canonical interface is more accessible in TvPPi-PFK than in available PPi-PFK structures, suggesting a previously unrecognized ligand-recognition feature. These findings expand the structural landscape of the PFK superfamily and provide a framework for testing how nucleotide and sugar-phosphate binding may influence TvPPi-PFK function, regulation, and future antitrichomonal drug-discovery efforts.
- Open Access
- 27 November 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 80 (12) , 341-347
Structures of Trichomonas vaginalis macrophage migratory inhibitory factor
The unicellular parasitic protozoan Trichomonas vaginalis causes trichomoniasis, the most prevalent nonviral sexually transmitted disease globally. T. vaginalis evades host immune responses by producing homologs of host proteins, including cytokines such as macrophage migration inhibitory factor. T. vaginalis macrophage migration inhibitory factor ( Tv MIF) helps to facilitate the survival of T. vaginalis during nutritional stress conditions, increases prostate cell proliferation and invasiveness, and induces inflammation-related cellular pathways, thus mimicking the ability of human MIF to increase inflammation and cell proliferation. The production, crystallization and three structures of N-terminally hexahistidine-tagged Tv MIF reveal a prototypical MIF trimer with a topology similar to that of human homologs (hMIF-1 and hMIF-2). The N-terminal tag obscures the expected pyruvate-binding site. The similarity of Tv MIF to its human homologs can be exploited for structure-based drug discovery.
- 27 November 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 80 (12) , 341-347
Open AccessStructures of Trichomonas vaginalis macrophage migratory inhibitory factor
The unicellular parasitic protozoan Trichomonas vaginalis causes trichomoniasis, the most prevalent nonviral sexually transmitted disease globally. T. vaginalis evades host immune responses by producing homologs of host proteins, including cytokines such as macrophage migration inhibitory factor. T. vaginalis macrophage migration inhibitory factor ( Tv MIF) helps to facilitate the survival of T. vaginalis during nutritional stress conditions, increases prostate cell proliferation and invasiveness, and induces inflammation-related cellular pathways, thus mimicking the ability of human MIF to increase inflammation and cell proliferation. The production, crystallization and three structures of N-terminally hexahistidine-tagged Tv MIF reveal a prototypical MIF trimer with a topology similar to that of human homologs (hMIF-1 and hMIF-2). The N-terminal tag obscures the expected pyruvate-binding site. The similarity of Tv MIF to its human homologs can be exploited for structure-based drug discovery.
- Open Access
- 6 November 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 80 (12) , 328-334
Crystal structure of N-terminally hexahistidine-tagged Onchocerca volvulus macrophage migration inhibitory factor-1
Onchocerca volvulus causes blindness, onchocerciasis, skin infections and devastating neurological diseases such as nodding syndrome. New treatments are needed because the currently used drug, ivermectin, is contraindicated in pregnant women and those co-infected with Loa loa . The Seattle Structural Genomics Center for Infectious Disease (SSGCID) produced, crystallized and determined the apo structure of N-terminally hexahistidine-tagged O. volvulus macrophage migration inhibitory factor-1 (His- Ov MIF-1). Ov MIF-1 is a possible drug target. His- Ov MIF-1 has a unique jellyfish-like structure with a prototypical macrophage migration inhibitory factor (MIF) trimer as the `head' and a unique C-terminal `tail'. Deleting the N-terminal tag reveals an Ov MIF-1 structure with a larger cavity than that observed in human MIF that can be targeted for drug repurposing and discovery. Removal of the tag will be necessary to determine the actual biological oligomer of Ov MIF-1 because size-exclusion chomatographic analysis of His- Ov MIF-1 suggests a monomer, while PISA analysis suggests a hexamer stabilized by the unique C-terminal tails.
- 6 November 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 80 (12) , 328-334
Open AccessCrystal structure of N-terminally hexahistidine-tagged Onchocerca volvulus macrophage migration inhibitory factor-1
Onchocerca volvulus causes blindness, onchocerciasis, skin infections and devastating neurological diseases such as nodding syndrome. New treatments are needed because the currently used drug, ivermectin, is contraindicated in pregnant women and those co-infected with Loa loa . The Seattle Structural Genomics Center for Infectious Disease (SSGCID) produced, crystallized and determined the apo structure of N-terminally hexahistidine-tagged O. volvulus macrophage migration inhibitory factor-1 (His- Ov MIF-1). Ov MIF-1 is a possible drug target. His- Ov MIF-1 has a unique jellyfish-like structure with a prototypical macrophage migration inhibitory factor (MIF) trimer as the `head' and a unique C-terminal `tail'. Deleting the N-terminal tag reveals an Ov MIF-1 structure with a larger cavity than that observed in human MIF that can be targeted for drug repurposing and discovery. Removal of the tag will be necessary to determine the actual biological oligomer of Ov MIF-1 because size-exclusion chomatographic analysis of His- Ov MIF-1 suggests a monomer, while PISA analysis suggests a hexamer stabilized by the unique C-terminal tails.
- 7 February 2023
- Published by Wiley in Advanced Materials
- Vol. 35 (11) , e2207673
Triplet Fusion Upconversion for Photocuring 3D‐Printed Particle‐Reinforced Composite Networks
High energy photons (λ < 400 nm) are frequently used to initiate free radical polymerizations to form polymer networks, but are only effective for transparent objects. This phenomenon poses a major challenge to additive manufacturing of particle‐reinforced composite networks since deep light penetration of short‐wavelength photons limits the homogeneous modification of physicochemical and mechanical properties. Herein, the unconventional, yet versatile, multiexciton process of triplet–triplet annihilation upconversion (TTA‐UC) is employed for curing opaque hydrogel composites created by direct‐ink‐write (DIW) 3D printing. TTA‐UC converts low energy red light (λmax = 660 nm) for deep penetration into higher‐energy blue light to initiate free radical polymerizations within opaque objects. As proof‐of‐principle, hydrogels containing up to 15 wt.% TiO2 filler particles and doped with TTA‐UC chromophores are readily cured with red light, while composites without the chromophores and TiO2 loadings as little as 1–2 wt.% remain uncured. Importantly, this method has wide potential to modify the chemical and mechanical properties of complex DIW 3D‐printed composite polymer networks.
- 7 February 2023
- Published by Wiley in Advanced Materials
- Vol. 35 (11) , e2207673
Triplet Fusion Upconversion for Photocuring 3D‐Printed Particle‐Reinforced Composite Networks
High energy photons (λ < 400 nm) are frequently used to initiate free radical polymerizations to form polymer networks, but are only effective for transparent objects. This phenomenon poses a major challenge to additive manufacturing of particle‐reinforced composite networks since deep light penetration of short‐wavelength photons limits the homogeneous modification of physicochemical and mechanical properties. Herein, the unconventional, yet versatile, multiexciton process of triplet–triplet annihilation upconversion (TTA‐UC) is employed for curing opaque hydrogel composites created by direct‐ink‐write (DIW) 3D printing. TTA‐UC converts low energy red light (λmax = 660 nm) for deep penetration into higher‐energy blue light to initiate free radical polymerizations within opaque objects. As proof‐of‐principle, hydrogels containing up to 15 wt.% TiO2 filler particles and doped with TTA‐UC chromophores are readily cured with red light, while composites without the chromophores and TiO2 loadings as little as 1–2 wt.% remain uncured. Importantly, this method has wide potential to modify the chemical and mechanical properties of complex DIW 3D‐printed composite polymer networks.